NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
78 hedge funds and large institutions have $60.2M invested in Navidea Biopharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $126M → $60.2M (-$66M)
97% less call options, than puts
Call options by funds: $213K | Put options by funds: $8.2M
Holders
78
Holding in Top 10
1
Calls
$213K
Puts
$8.2M
Top Buyers
| 1 | +$255K | |
| 2 | +$223K | |
| 3 | +$149K | |
| 4 |
D.E. Shaw & Co
New York
|
+$138K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$138K |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$1.85M | |
| 3 | -$546K | |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$427K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$300K |